RS49526B - Derivati triazola korisni u terapiji - Google Patents
Derivati triazola korisni u terapijiInfo
- Publication number
- RS49526B RS49526B YU2997A YU2997A RS49526B RS 49526 B RS49526 B RS 49526B YU 2997 A YU2997 A YU 2997A YU 2997 A YU2997 A YU 2997A RS 49526 B RS49526 B RS 49526B
- Authority
- RS
- Serbia
- Prior art keywords
- phenyl substituted
- therapy
- halogen
- group
- triazole derivatives
- Prior art date
Links
- 229940042055 systemic antimycotics triazole derivative Drugs 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 230000001419 dependent effect Effects 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
- 230000000843 anti-fungal effect Effects 0.000 abstract 1
- 229940121375 antifungal agent Drugs 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- -1 methylpyrazolyl Chemical group 0.000 abstract 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 150000003852 triazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having three nitrogen atoms as the only ring hetero atoms
- C07F9/6518—Five-membered rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
1. Jedinjenje formule I: R1-OP(O)(OH)2 (I) gde R1 predstavlja ne-hidroksi deo antifungalnog jedinjenja triazola koje sadrži tercijarnu hidroksi grupu; ili njegova farmaceutski prihvatljiva so. 2. Jedinjenje prema zahevu 1, naznačeno time, što je R1 grupa formule Ia: gde R2 predstavlja fenil supstituisan jednim ili više halogenih atoma; R3 predstavlja H ili CH3; R3a predstavlja H, ili zajedno sa R3 može predstavljati =CH2 i R4 predstavlja 5- ili 6-člani heterociklični prsten koji sadrži azot, koji je po potrebi supstituisan jednom ili više grupa odabranih od halogena, =O, fenila supstituisanog jednom grupom odabranom od CN i (C6H4)-OCH2CF2CHF2 ili CH=CH-(C6H4)-OCH2CF2CHF2 ili fenil supstituisan jednom ili više grupa odabranih od halogena i metilpirazolila. Prijava sadrži još 5 zavisnih patentnih zahteva, 6 nezavisnih patentnih zahteva i 1 zavisan patentni zahtev.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9602080.5A GB9602080D0 (en) | 1996-02-02 | 1996-02-02 | Pharmaceutical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
YU2997A YU2997A (sh) | 2000-10-30 |
RS49526B true RS49526B (sr) | 2006-12-15 |
Family
ID=10787975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YU2997A RS49526B (sr) | 1996-02-02 | 1997-01-28 | Derivati triazola korisni u terapiji |
Country Status (43)
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9602080D0 (en) * | 1996-02-02 | 1996-04-03 | Pfizer Ltd | Pharmaceutical compounds |
GB9713149D0 (en) | 1997-06-21 | 1997-08-27 | Pfizer Ltd | Pharmaceutical formulations |
DE19751525C2 (de) | 1997-11-20 | 2003-02-13 | Bat Cigarettenfab Gmbh | Verfahren und Vorrichtung zur Regelung der Ausgangsfeuchte von Tabak |
US6265584B1 (en) | 1998-05-22 | 2001-07-24 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
WO2000030655A1 (en) * | 1998-11-20 | 2000-06-02 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
US6235728B1 (en) | 1999-02-19 | 2001-05-22 | Bristol-Myers Squibb Company | Water-soluble prodrugs of azole compounds |
KR20010050557A (ko) * | 1999-09-29 | 2001-06-15 | 타이도 나오카타 | 아졸 유도체 또는 그의 염 |
US6362172B2 (en) * | 2000-01-20 | 2002-03-26 | Bristol-Myers Squibb Company | Water soluble prodrugs of azole compounds |
US6448401B1 (en) * | 2000-11-20 | 2002-09-10 | Bristol-Myers Squibb Company | Process for water soluble azole compounds |
US7540402B2 (en) * | 2001-06-29 | 2009-06-02 | Kva, Inc. | Method for controlling weld metal microstructure using localized controlled cooling of seam-welded joints |
US7323572B2 (en) | 2002-07-16 | 2008-01-29 | Pfizer Inc | Process for controlling the hydrate mix of a compound |
WO2005006860A2 (en) * | 2003-07-18 | 2005-01-27 | The Board Of Governors For Higher Education State Of Rhode Island And Providence Plantations | Azole derivatives and methods for making the same |
KR20070085093A (ko) * | 2004-03-24 | 2007-08-27 | 파스젠, 엘엘씨. | Amp-활성화 단백질 키나아제의 약리학적 저해에 의한신규한 신경 보호 방법 |
CN1303073C (zh) * | 2005-05-31 | 2007-03-07 | 中国人民解放军第二军医大学 | 取代三唑酮苄胺三唑醇类抗真菌化合物及其制备方法 |
JP5046959B2 (ja) * | 2005-12-20 | 2012-10-10 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 水溶性アゾールプロドラッグの製造方法 |
BRPI0620715A2 (pt) | 2005-12-27 | 2011-11-22 | Otsuka Pharma Co Ltd | composto da benzoazepina solúvel em água e a sua composição farmacêutica |
ATE482700T1 (de) * | 2006-02-22 | 2010-10-15 | Eisai R&D Man Co Ltd | Stabilisierte pharmazeutische zusammensetzung |
PE20091778A1 (es) * | 2008-04-15 | 2009-11-13 | Schering Corp | Composiciones de alta densidad que contienen posaconazol y formulaciones que lo comprenden |
CN101575330B (zh) * | 2008-05-05 | 2012-10-31 | 丽珠医药集团股份有限公司 | 伏立康唑广谱抗真菌药物化合物、其组合物及用途 |
WO2011064558A2 (en) | 2009-11-30 | 2011-06-03 | Cipla Limited | Pharmaceutical composition |
EA032840B8 (ru) | 2011-06-22 | 2020-06-18 | Вайоми Терапеутикс Лимитед | Пролекарства на основе конъюгатов противогрибковых агентов и их применение |
EP2561863A1 (en) | 2011-08-22 | 2013-02-27 | Farmaprojects, S.A.U. | Pharmaceutical compositions comprising voriconazole |
EA026209B1 (ru) | 2012-01-20 | 2017-03-31 | Ваймет Фармасьютикалс, Инк. | Соединения, ингибирующие металлоферменты |
RS59960B1 (sr) * | 2012-03-19 | 2020-03-31 | Cidara Therapeutics Inc | Dozni režimi za jedinjenja klase ehinokandina |
CN103864844B (zh) * | 2012-12-09 | 2016-10-05 | 正大天晴药业集团股份有限公司 | 一种福司氟康唑的制备方法 |
CN103304600B (zh) * | 2013-03-04 | 2018-05-25 | 陕西合成药业股份有限公司 | 一种伏立康唑磷酸酯三水合物及其制备方法和用途 |
WO2014182368A2 (en) | 2013-03-14 | 2014-11-13 | Fresenius Kabi Usa, Llc | Voriconazole formulations |
RU2719579C2 (ru) * | 2013-03-14 | 2020-04-21 | Сидара Терапьютикс, Инк. | Режимы дозирования для соединений класса эхинокандинов |
EA201592236A1 (ru) | 2013-06-04 | 2016-06-30 | Вайом Байосайнсиз Пвт. Лтд. | Частицы с нанесенным покрытием и композиции, включающие такие частицы |
CN103524560A (zh) * | 2013-09-28 | 2014-01-22 | 陕西合成药业有限公司 | 伏立康磷酸酯钠水合物及其多晶型 |
CN104650140B (zh) * | 2013-11-18 | 2017-11-10 | 正大天晴药业集团股份有限公司 | 一种高纯度福司氟康唑的制备方法 |
BR112016017690A2 (pt) | 2014-01-29 | 2017-08-08 | Vyome Biosciences Pvt Ltd | Tratamentos para acne resistente |
CN104860992A (zh) * | 2014-02-25 | 2015-08-26 | 陕西合成药业股份有限公司 | 一种高纯度福司氟康唑制备方法 |
CN105985377A (zh) * | 2015-02-09 | 2016-10-05 | 陕西合成药业股份有限公司 | 一种福司氟康唑盐水合物及其制备方法 |
CN106279280A (zh) * | 2015-05-25 | 2017-01-04 | 西藏卫信康医药股份有限公司 | 一种化合物及其制备方法和应用 |
CN106518922A (zh) * | 2015-09-12 | 2017-03-22 | 陕西合成药业股份有限公司 | 一种三唑类化合物及其制备方法和用途 |
CN106546668A (zh) * | 2015-09-22 | 2017-03-29 | 陕西合成药业股份有限公司 | 一种分离福司氟康唑或其药用盐有关物质的hplc方法 |
CN105237569B (zh) * | 2015-10-21 | 2017-07-25 | 西南科技大学 | 一种制备2,4‑二氟‑α,α‑二(1氢‑1,2,4‑三唑‑1‑基甲基)苯甲醇磷酸二苄酯的合成方法 |
CN105753902B (zh) * | 2016-04-11 | 2017-08-25 | 浙江诚意药业股份有限公司 | 一种福司氟康唑的制备方法 |
CN108676031A (zh) * | 2018-05-29 | 2018-10-19 | 重庆威鹏药业有限公司 | 水溶性三唑类抗真菌膦酸化合物及其制备方法和应用 |
CN111171075B (zh) * | 2020-04-03 | 2022-07-12 | 北京四环生物制药有限公司 | 一种福司氟康唑的制备方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2099818A (en) * | 1981-06-06 | 1982-12-15 | Pfizer Ltd | Triazoles |
US4528284A (en) * | 1982-10-15 | 1985-07-09 | Ciba-Geigy Corporation | Fungicidal 2-(azolylmethyl-1'-yl)-2-aryl-2-(cyano, alkoxycarbonyl, alkylthiocarbonyl and aminocarbonyl)-2-phosphorus acid esters |
US4952232A (en) * | 1987-04-29 | 1990-08-28 | E. I. Du Pont De Nemours And Company | Antifungal carbinols |
US5043273A (en) * | 1989-08-17 | 1991-08-27 | Monsanto Company | Phosphorylated glycosidase inhibitor prodrugs |
US5278175A (en) * | 1990-02-02 | 1994-01-11 | Pfizer Inc. | Triazole antifungal agents |
GB9002375D0 (en) * | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
TW211006B (sr) * | 1990-08-24 | 1993-08-11 | Mochida Pharm Co Ltd | |
TW218017B (sr) * | 1992-04-28 | 1993-12-21 | Takeda Pharm Industry Co Ltd | |
US5358939A (en) * | 1992-06-25 | 1994-10-25 | Rohm And Haas Company | Fungicidal 2-aryl-2,2-disubstituted ethyl-1,2,4-triazoles |
PT741737E (pt) * | 1994-01-24 | 2000-04-28 | Janssen Pharmaceutica Nv | Antifungicos do tipo azole soluveis em agua |
NZ270418A (en) * | 1994-02-07 | 1997-09-22 | Eisai Co Ltd | Polycyclic triazole & imidazole derivatives, antifungal compositions |
US5814324A (en) * | 1994-02-25 | 1998-09-29 | Takeda Chemical Industries, Ltd. | Injectable composition and a method of producing the same |
GB9512961D0 (en) * | 1995-06-26 | 1995-08-30 | Pfizer Ltd | Antifungal agents |
FR2741061B1 (fr) * | 1995-11-13 | 1998-03-20 | Alcatel Fibres Optiques | Procede de fabrication d'une fibre optique monomode et amplificateur optique utilisant une telle fibre |
GB9602080D0 (en) * | 1996-02-02 | 1996-04-03 | Pfizer Ltd | Pharmaceutical compounds |
US5767977A (en) * | 1996-12-19 | 1998-06-16 | Hewlett-Packard Co. | Method and apparatus for a carriage latch and power cord lock-out system for an optical scanner |
-
1996
- 1996-02-02 GB GBGB9602080.5A patent/GB9602080D0/en active Pending
- 1996-12-27 TW TW085116150A patent/TW434247B/zh not_active IP Right Cessation
-
1997
- 1997-01-27 EP EP97902288A patent/EP0880533B1/en not_active Expired - Lifetime
- 1997-01-27 SA SA97170578A patent/SA97170578B1/ar unknown
- 1997-01-27 DE DE69713284T patent/DE69713284T2/de not_active Expired - Fee Related
- 1997-01-27 WO PCT/EP1997/000445 patent/WO1997028169A1/en active IP Right Grant
- 1997-01-27 SI SI9730341T patent/SI0880533T1/xx unknown
- 1997-01-27 HU HU9900949A patent/HU226133B1/hu not_active IP Right Cessation
- 1997-01-27 CZ CZ19982420A patent/CZ291431B6/cs not_active IP Right Cessation
- 1997-01-27 ES ES97902288T patent/ES2175336T3/es not_active Expired - Lifetime
- 1997-01-27 BR BR9707257A patent/BR9707257A/pt active Search and Examination
- 1997-01-27 JP JP9527312A patent/JP2959846B2/ja not_active Expired - Lifetime
- 1997-01-27 PT PT97902288T patent/PT880533E/pt unknown
- 1997-01-27 DK DK97902288T patent/DK0880533T3/da active
- 1997-01-27 RU RU98116435/04A patent/RU2176244C2/ru not_active IP Right Cessation
- 1997-01-27 AU AU15985/97A patent/AU709781B2/en not_active Ceased
- 1997-01-27 TR TR1998/01440T patent/TR199801440T2/xx unknown
- 1997-01-27 UA UA98094671A patent/UA46828C2/uk unknown
- 1997-01-27 HN HN1997000012A patent/HN1997000012A/es unknown
- 1997-01-27 AT AT97902288T patent/ATE219089T1/de not_active IP Right Cessation
- 1997-01-27 SK SK1022-98A patent/SK283136B6/sk not_active IP Right Cessation
- 1997-01-27 PL PL97328436A patent/PL187237B1/pl not_active IP Right Cessation
- 1997-01-27 KR KR1019980705961A patent/KR100283546B1/ko not_active IP Right Cessation
- 1997-01-27 IL IL12486597A patent/IL124865A/en not_active IP Right Cessation
- 1997-01-27 CA CA002240777A patent/CA2240777C/en not_active Expired - Fee Related
- 1997-01-27 CN CN97192005A patent/CN1085213C/zh not_active Expired - Lifetime
- 1997-01-27 NZ NZ330654A patent/NZ330654A/xx unknown
- 1997-01-28 RS YU2997A patent/RS49526B/sr unknown
- 1997-01-29 TN TNTNSN97023A patent/TNSN97023A1/fr unknown
- 1997-01-29 DZ DZ970017A patent/DZ2172A1/fr active
- 1997-01-30 AP APAP/P/1997/000923A patent/AP678A/en active
- 1997-01-30 GT GT199700016A patent/GT199700016A/es unknown
- 1997-01-31 ID IDP970289A patent/ID15858A/id unknown
- 1997-01-31 MY MYPI97000389A patent/MY116849A/en unknown
- 1997-01-31 ZA ZA97826A patent/ZA97826B/xx unknown
- 1997-01-31 CO CO97004868A patent/CO4761066A1/es unknown
- 1997-01-31 HR HR970063A patent/HRP970063B1/xx not_active IP Right Cessation
-
1998
- 1998-06-11 IL IL13313598A patent/IL133135A/xx not_active IP Right Cessation
- 1998-06-26 IS IS4785A patent/IS1995B/is unknown
- 1998-07-06 BG BG102603A patent/BG63946B1/bg unknown
- 1998-07-10 OA OA9800110A patent/OA10711A/en unknown
- 1998-08-03 NO NO19983560A patent/NO323771B1/no not_active IP Right Cessation
-
1999
- 1999-07-29 HK HK99103264A patent/HK1018217A1/xx not_active IP Right Cessation
- 1999-11-25 IL IL13313599A patent/IL133135A0/xx unknown
-
2003
- 2003-01-09 US US10/339,087 patent/US6790957B2/en not_active Expired - Fee Related
-
2004
- 2004-03-26 US US10/810,100 patent/US6977302B2/en not_active Expired - Fee Related
-
2005
- 2005-01-28 US US11/046,266 patent/US20050130940A1/en not_active Abandoned
-
2006
- 2006-09-29 US US11/540,375 patent/US20070027115A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49526B (sr) | Derivati triazola korisni u terapiji | |
ES2069137T3 (es) | Derivados de imidazopiridina y su uso. | |
FI934274A (fi) | N-sulfonyl-2-oxi-indolderivat, deras framstaellning och dessa innehaollande farmaceutiska kompositioner | |
ATE74134T1 (de) | Rapamycin-vorlaeufer. | |
DE3475905D1 (en) | Dopamine-beta-hydroxylase inhibitors | |
NZ332608A (en) | alkyl 17-alpha-dichloroacetoxy-11- beta-hydroxy-androsta-1,4-diene-3-one-17-beta-carboxylates and medicaments | |
DE69728544D1 (de) | Totalsynthese von acylfulvenen mit antitumorwirkung | |
FI860369A (fi) | Imidazolderivat, deras framstaellning och anvaendning samt dessa derivat innehaollande farmaceutiska kompositioner. | |
YU47298B (sh) | Derivati 16-dehidro-vitamina d3 | |
DE69311118D1 (de) | Phosphono-arylethanolamin-verbindungen mit antihyperglykämischer und/oder antiobeser wirkung | |
RS49965B (sr) | Supstituisani bisindolmaleimidi za inhibiciju ćelijske proliferacije | |
ES8306474A1 (es) | Derivados de encefalina. | |
YU142791A (sh) | Heterociklična jedinjenja | |
IL48453A (en) | Substituted 6-oxa-1-azatricyclo-(6.2.2.0 )dodecan-5-ones and 1,4-ethano-5-oxo octa (or decahydro)quinoline,their preparation and pharmaceutical compositions containing them | |
HUP9903526A2 (hu) | Pirimidinszármazékok és az ezeket tartalmazó gyógyszerkészítmények | |
EP1056700A4 (en) | MEDICAL APPLICATIONS OF PHENYL ALCOHOLS AND DERIVATIVES THEREOF | |
IT1255207B (it) | Composizioni farmaceutuche ad attivita' antiaggregante e vasodilatatrice | |
ATE34173T1 (de) | Thiazolderivate als h2-rezeptor-antagonisten. | |
FI922981A (fi) | 2-aminopyrimidin-4-karboxamidderivat, framstaellning av dessa och terapeutisk anvaendning av dessa | |
ES556048A0 (es) | Un procedimiento para la preparacion de un derivado de tiazolidina. | |
DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
DE69707793D1 (de) | Alkynylaminosäure Derivate und ihre Verwendung als pharmazeutische Verbindungen | |
AR030927A1 (es) | Compuestos de azol, su uso para preparar una composicion farmaceutica, dicha composicion farmaceutica y proceso para la preparacion del mismo |